Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Disalan
2. Flukanide
3. Mk 990
4. Rafoxanid
5. Ranide
1. 22662-39-1
2. Disalan
3. Ranide
4. Flukanide
5. Bovanide
6. Duofas
7. Ranide, Veterinary
8. 3'-chloro-4'-(4-chlorophenoxy)-3,5-diiodosalicylanilide
9. Mk-990
10. N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide
11. 3'-chloro-4'-(p-chlorophenoxy)-3,5-diiodosalicylanilide
12. Nsc-355278
13. N-(3-chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodobenzamide
14. 22f4fla7dh
15. Benzamide, N-(3-chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodo-
16. Salicylanilide, 3'-chloro-4'-(p-chlorophenoxy)-3,5-diiodo-
17. Nsc355278
18. Ncgc00160556-01
19. Dsstox_cid_26227
20. Dsstox_rid_81454
21. Dsstox_gsid_46227
22. Rafoxanida
23. Rafoxanidum
24. Rafoxanidum [inn-latin]
25. Rafoxanida [inn-spanish]
26. Nsc 355278
27. Cas-22662-39-1
28. Einecs 245-148-9
29. Unii-22f4fla7dh
30. Brn 2228187
31. Rafoxanide [usan:inn:ban]
32. Ai3-29020
33. Rafoxanide Vetranal
34. 3'-chlor-4'-(4-chlorphenoxy)-3,5-diiodsalicylanilid
35. Rafoxanide [mi]
36. Rafoxanide [inn]
37. Rafoxanide (usan/inn)
38. Salicylanilide,5-diiodo-
39. Rafoxanide [usan]
40. Rafoxanide [mart.]
41. Mls001240273
42. Schembl118031
43. Chembl287542
44. Dtxsid5046227
45. Hms2233m19
46. Bcp15963
47. N-(3-chloro-4-(4-chlorophenoxy)
48. Zinc4181896
49. Tox21_111896
50. Bdbm50022832
51. Mfcd00682899
52. Stk377482
53. Akos003631075
54. N-[3-chloro-4-(4-chloro-phenoxy)-phenyl]-2-hydroxy-3,5-diiodo-benzamide
55. N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodo-benzamide
56. Rafoxanide 100 Microg/ml In Methanol
57. Tox21_111896_1
58. Ccg-270276
59. Cs-3979
60. Ks-1309
61. Phenyl)-2-hydroxy-3,5-diiodobenzamide
62. Wln: Qr Bi Di Fvmr Cg Dor Dg
63. Ncgc00160556-02
64. Ac-20061
65. Hy-17598
66. Smr000768692
67. Db-045962
68. Ft-0630489
69. R0108
70. S5093
71. Rafoxanide, Pestanal(r), Analytical Standard
72. C74169
73. D05693
74. 662r391
75. J-014804
76. Q12048733
77. 3'-chloro-4'-(p-chlorophenoxy)-3, 5-diiodosalicylanilide
78. 3,5-diiodo-3'-chloro-4'-(p-chlorophenoxy)-salicylanilide
79. 3-chloro-4-(4-chlorophenoxy)-3,5-diiodosalicylanilide
80. Benzamide, {n-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,} 5-diiodo-
81. Benzamide, N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodo- [
| Molecular Weight | 626.0 g/mol |
|---|---|
| Molecular Formula | C19H11Cl2I2NO3 |
| XLogP3 | 7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 624.82054 g/mol |
| Monoisotopic Mass | 624.82054 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 507 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
Antiplatyhelmintic Agents
Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. (See all compounds classified as Antiplatyhelmintic Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Rafoxanide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rafoxanide, including repackagers and relabelers. The FDA regulates Rafoxanide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rafoxanide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rafoxanide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rafoxanide supplier is an individual or a company that provides Rafoxanide active pharmaceutical ingredient (API) or Rafoxanide finished formulations upon request. The Rafoxanide suppliers may include Rafoxanide API manufacturers, exporters, distributors and traders.
click here to find a list of Rafoxanide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Rafoxanide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rafoxanide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rafoxanide GMP manufacturer or Rafoxanide GMP API supplier for your needs.
A Rafoxanide CoA (Certificate of Analysis) is a formal document that attests to Rafoxanide's compliance with Rafoxanide specifications and serves as a tool for batch-level quality control.
Rafoxanide CoA mostly includes findings from lab analyses of a specific batch. For each Rafoxanide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rafoxanide may be tested according to a variety of international standards, such as European Pharmacopoeia (Rafoxanide EP), Rafoxanide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rafoxanide USP).
LOOKING FOR A SUPPLIER?
